NJ State Employees Deferred Compensation Plan’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Hold |
14,000
| – | – | 0.02% | 410 |
|
|
2025
Q1 | $64K | Hold |
14,000
| – | – | 0.01% | 434 |
|
|
2024
Q4 | $79K | Hold |
14,000
| – | – | 0.01% | 448 |
|
|
2024
Q3 | $67.8K | Hold |
14,000
| – | – | 0.01% | 462 |
|
|
2024
Q2 | $68.3K | Hold |
14,000
| – | – | 0.01% | 457 |
|
|
2024
Q1 | $186K | Hold |
14,000
| – | – | 0.02% | 441 |
|
|
2023
Q4 | $195K | Hold |
14,000
| – | – | 0.03% | 439 |
|
|
2023
Q3 | $186K | Hold |
14,000
| – | – | 0.03% | 435 |
|
|
2023
Q2 | $263K | Hold |
14,000
| – | – | 0.04% | 395 |
|
|
2023
Q1 | $202K | Hold |
14,000
| – | – | 0.03% | 436 |
|
|
2022
Q4 | $271K | Hold |
14,000
| – | – | 0.04% | 379 |
|
|
2022
Q3 | $481K | Buy |
+14,000
| New | +$481K | 0.08% | 252 |
|